Department of Pathology and Laboratory Medicine, Omori Red Cross Hospital, Tokyo 143-8527, Japan.
Thyroid Examination Expert Committee, Diagnostic Criteria Subcommittee for the Fukushima Health Management Survey, Fukushima Medical University, Fukushima 960-1295, Japan.
Endocr J. 2021 Jun 28;68(6):621-630. doi: 10.1507/endocrj.EJ21-0077. Epub 2021 Apr 13.
Histological classification and cytology reporting format described in General Rules for the Description of Thyroid Cancer, the 8 edition (2019) (the Japanese General Rules) were briefly introduced. Moreover, the differences between "the Japanese General Rules", and WHO Histological Classification, the 4 edition (2017) and The Bethesda System for Reporting Thyroid Cytopathology, the 2 edition (2018) were also explained. The Japanese General Rules did not accept the borderline lesions of thyroid tumor which were newly shown in WHO Histological Classification. We believe it is not necessary to introduce these borderline lesions in daily practice in Japan. Borderline lesions were proposed for avoiding over-surgery for thyroid cancer patients. In the United States, when the patient is diagnosed as malignant on cytology, total thyroidectomy is generally recommended. However, there is no over-surgery in Japan, because surgeons have several choices of treatment for thyroid cancer patients. This article is the first that the Japanese General Rules was shown by foreign language. Therefore, this will be advantageous to us when we present our opinion concerning histology and cytology of thyroid tumor to the world.
简要介绍了《甲状腺癌描述的一般规则》第 8 版（2019 年）（日本一般规则）中描述的组织学分类和细胞学报告格式。此外，还解释了“日本一般规则”与世界卫生组织组织学分类第 4 版（2017 年）和《甲状腺细胞病理学报告的贝塞斯达系统》第 2 版（2018 年）之间的差异。日本一般规则不接受世界卫生组织组织学分类中新出现的甲状腺肿瘤交界性病变。我们认为在日本的日常实践中没有必要引入这些交界性病变。交界性病变的提出是为了避免对甲状腺癌患者进行过度手术。在美国，当患者的细胞学检查被诊断为恶性时，通常建议行甲状腺全切除术。然而，在日本没有过度手术，因为外科医生对甲状腺癌患者有多种治疗选择。这是第一篇以外语展示日本一般规则的文章。因此，当我们向世界展示我们对甲状腺肿瘤的组织学和细胞学的意见时，这将对我们有利。
